LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹525 Cr | ₹463 Cr | ₹391 Cr | ₹373 Cr | ₹328 Cr |
What is the latest Total Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹525 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹391 Cr |
| Mar2022 | ₹373 Cr |
| Mar2021 | ₹328 Cr |
How is Total Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹525 Cr | 13.37 | |
| Mar2024 | ₹463 Cr | 18.37 | |
| Mar2023 | ₹391 Cr | 4.83 | |
| Mar2022 | ₹373 Cr | 13.85 | |
| Mar2021 | ₹328 Cr | - | |
Compare Total Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,159.9 Cr | 0.1% | -6.5% | 6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.1% |
-6.5% |
6.9% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses